Ingrid Zahn, Hannah Franke, Sophie Gleixner, Nicolas Blavet, Jana Dietrich, Philipp Arnold, Friedrich Paulsen
{"title":"Intrinsic regeneration mechanisms of murine lacrimal gland epithelial cells for therapeutic applications in aqueous-deficient dry eye disease","authors":"Ingrid Zahn, Hannah Franke, Sophie Gleixner, Nicolas Blavet, Jana Dietrich, Philipp Arnold, Friedrich Paulsen","doi":"10.1016/j.jtos.2026.06.007","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><div>Aqueous-deficient dry eye disease (ADDE) results from lacrimal gland dysfunction leading to tear film instability and chronic ocular surface inflammation. Despite the gland's known regenerative potential, the intrinsic molecular mechanisms enabling epithelial recovery remain poorly understood. This study aimed to characterize intrinsic regeneration processes of murine lacrimal gland epithelial cells (mLGECs) and identify pathways with therapeutic potential.</div></div><div><h3>Methods</h3><div>Primary mLGECs were isolated from neonatal C57BL/6J mice and characterized. Acute injury was induced by brief exposure to 20% ethanol. Metabolic activity, apoptosis, and transcriptional responses were analyzed during early recovery phases. Pathway enrichment was conducted using Gene Ontology and KEGG annotations. Regeneration-associated growth factors were validated by qPCR, ELISA, and metabolic activity and wound closure assays in the presence or absence of the MAPK inhibitor SCH772984. MAPK activation was assessed by ERK1/2 phosphorylation.</div></div><div><h3>Results</h3><div>mLGECs retained expression of epithelial and lacrimal-specific markers and exhibited regulated secretory activity. RNA sequencing and ERK1/2 phosphorylation revealed activation of MAPK signaling, accompanied by strong upregulation of regenerative ligands including Hbegf, Areg, Ngf, and Gdnf. Transient protein induction of HBEGF and AREG was confirmed. Functionally, HBEGF, AREG, NGF, and GDNF markedly enhanced metabolic recovery and wound closure, whereas pharmacological MAPK inhibition markedly impaired recovery.</div></div><div><h3>Conclusion</h3><div>These results identify MAPK signaling as a major component of the intrinsic epithelial injury response in lacrimal gland cells. HBEGF and AREG emerged as prominent mediators associated with enhanced recovery. The findings provide a mechanistic basis for developing defined growth factor–based approaches to support lacrimal gland epithelial regeneration.</div></div>","PeriodicalId":54691,"journal":{"name":"Ocular Surface","volume":"41 ","pages":"Pages 233-248"},"PeriodicalIF":6.6000,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ocular Surface","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S154201242600073X","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/6/13 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose
Aqueous-deficient dry eye disease (ADDE) results from lacrimal gland dysfunction leading to tear film instability and chronic ocular surface inflammation. Despite the gland's known regenerative potential, the intrinsic molecular mechanisms enabling epithelial recovery remain poorly understood. This study aimed to characterize intrinsic regeneration processes of murine lacrimal gland epithelial cells (mLGECs) and identify pathways with therapeutic potential.
Methods
Primary mLGECs were isolated from neonatal C57BL/6J mice and characterized. Acute injury was induced by brief exposure to 20% ethanol. Metabolic activity, apoptosis, and transcriptional responses were analyzed during early recovery phases. Pathway enrichment was conducted using Gene Ontology and KEGG annotations. Regeneration-associated growth factors were validated by qPCR, ELISA, and metabolic activity and wound closure assays in the presence or absence of the MAPK inhibitor SCH772984. MAPK activation was assessed by ERK1/2 phosphorylation.
Results
mLGECs retained expression of epithelial and lacrimal-specific markers and exhibited regulated secretory activity. RNA sequencing and ERK1/2 phosphorylation revealed activation of MAPK signaling, accompanied by strong upregulation of regenerative ligands including Hbegf, Areg, Ngf, and Gdnf. Transient protein induction of HBEGF and AREG was confirmed. Functionally, HBEGF, AREG, NGF, and GDNF markedly enhanced metabolic recovery and wound closure, whereas pharmacological MAPK inhibition markedly impaired recovery.
Conclusion
These results identify MAPK signaling as a major component of the intrinsic epithelial injury response in lacrimal gland cells. HBEGF and AREG emerged as prominent mediators associated with enhanced recovery. The findings provide a mechanistic basis for developing defined growth factor–based approaches to support lacrimal gland epithelial regeneration.
期刊介绍:
The Ocular Surface, a quarterly, a peer-reviewed journal, is an authoritative resource that integrates and interprets major findings in diverse fields related to the ocular surface, including ophthalmology, optometry, genetics, molecular biology, pharmacology, immunology, infectious disease, and epidemiology. Its critical review articles cover the most current knowledge on medical and surgical management of ocular surface pathology, new understandings of ocular surface physiology, the meaning of recent discoveries on how the ocular surface responds to injury and disease, and updates on drug and device development. The journal also publishes select original research reports and articles describing cutting-edge techniques and technology in the field.
Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.
Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center